These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28611023)

  • 1. Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.
    Selimoglu-Buet D; Badaoui B; Benayoun E; Toma A; Fenaux P; Quesnel B; Etienne G; Braun T; Abermil N; Morabito M; Droin N; Solary E; Wagner-Ballon O;
    Blood; 2017 Aug; 130(6):832-835. PubMed ID: 28611023
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML.
    Schuler E; Frank F; Hildebrandt B; Betz B; Strupp C; Rudelius M; Aul C; Schroeder T; Gattermann N; Haas R; Germing U
    Leuk Res; 2018 Feb; 65():1-4. PubMed ID: 29216536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis.
    Talati C; Zhang L; Shaheen G; Kuykendall A; Ball M; Zhang Q; Lancet JE; Zuckerman KS; List AF; Komrokji R; Moscinski L; Padron E
    Blood; 2017 Mar; 129(13):1881-1883. PubMed ID: 28159734
    [No Abstract]   [Full Text] [Related]  

  • 4. Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Castoldi G
    Haematologica; 1997; 82(1):25-30. PubMed ID: 9107078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders.
    Yuo A; Miyazono K; Urabe A; Takaku F
    Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome].
    Neuwirtová R; Malasková V; Steruská M; Indrák K; Vozobulová V; Haber J; Smolíková A; Musilová J; Jelínek J
    Vnitr Lek; 1990 Aug; 36(8):738-45. PubMed ID: 2136457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic myelomonocytic leukemia.
    Storniolo AM; Moloney WC; Rosenthal DS; Cox C; Bennett JM
    Leukemia; 1990 Nov; 4(11):766-70. PubMed ID: 2232890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated neutrophil morphology and its utility in the assessment of neutrophil dysplasia.
    Miguel A; Orero M; Simon R; Collado R; Perez PL; Pacios A; Iglesias R; Martinez A; Carbonell F
    Lab Hematol; 2007; 13(3):98-102. PubMed ID: 17984041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous serum thrombopoietin concentrations in patients with myelodysplastic syndromes.
    Zwierzina H; Rollinger-Holzinger I; Nuessler V; Herold M; Meng YG
    Leukemia; 1998 Jan; 12(1):59-64. PubMed ID: 9436921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of peripheral blood flow cytometry in differentiating low grade versus high grade myelodysplastic syndromes (MDS) and in the evaluation of cytopenias.
    Rashidi HH; Xu X; Wang HY; Shafi NQ; Rameshkumar K; Messer K; Smith BR; Rose MG
    Int J Clin Exp Pathol; 2012; 5(3):224-30. PubMed ID: 22558477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real Life Data on Efficacy and Safety of Azacitidine Therapy for Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia.
    Helbig G; Chromik K; Woźniczka K; Kopińska AJ; Boral K; Dworaczek M; Koclęga A; Armatys A; Panz-Klapuch M; Markiewicz M
    Pathol Oncol Res; 2019 Jul; 25(3):1175-1180. PubMed ID: 30613922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
    Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
    Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myelomonocytic leukaemia (CMML)--a myelodysplastic or myeloproliferative syndrome?
    Michaux JL; Martiat P
    Leuk Lymphoma; 1993 Jan; 9(1-2):35-41. PubMed ID: 8477199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center.
    González-Medina I; Bueno J; Torrequebrada A; López A; Vallespí T; Massagué I
    Leuk Res; 2002 Sep; 26(9):821-4. PubMed ID: 12127557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of monocytosis in patients with myeloproliferative disorders.
    Beran M; Shen Y; Onida F; Wen S; Kantarjian H; Estey E
    Leuk Lymphoma; 2006 Mar; 47(3):417-23. PubMed ID: 16396764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance and application value of multiparameter flow cytometry for differentiation of immunophenotype in chronic myelomonocytic leukemia, myelodysplastic syndrome and acute monocytic leukemia].
    Wang YX; Zhang JH; Hu YP; Cao FF; Zhang N; Chen F; Liu X; Zhang MY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):857-62. PubMed ID: 22931642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia (CMML)--characterization of clinical features and prognosis.
    Hotta T; Utsumi M
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1441-7. PubMed ID: 3247819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.